#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4613052	Binding	Inhibition of HIF1 transactivation activity in HEK293T cells transfected with pGL3-5HRE-VEGF-luciferase at 0.01 to 1 uM incubated for 24 hrs under hypoxia condition by luciferase reporter gene assay	Homo sapiens	11	ALA4610125	cell-based format	Scientific Literature
2.	ALA4613053	Functional	Antitumor activity against mouse LLC cells allografted in C57BL/6J mouse assessed as inhibition of tumor growth at 5 mg/kg, ip dosed every 3 days for 17 days starting from 2 days after inoculation relative to control	Mus musculus	2	ALA4610125	organism-based format	Scientific Literature
3.	ALA4613054	Functional	Antitumor activity against mouse LLC cells allografted in C57BL/6J mouse assessed as inhibition of tumor growth at 5 mg/kg, ip dosed every 3 days for 17 days starting from 2 days after inoculation and co-treated with 5 mg/kg, ip EGFR inhibitor gefitinib relative to control	Mus musculus	1	ALA4610125	organism-based format	Scientific Literature
4.	ALA4613055	Functional	Antitumor activity against mouse LLC cells allografted in C57BL/6J mouse assessed as reduction tumor weight at 5 mg/kg, ip dosed every 3 days for 17 days starting from 2 days after inoculation relative to control	Mus musculus	2	ALA4610125	organism-based format	Scientific Literature
5.	ALA4613056	Functional	Antitumor activity against mouse LLC cells allografted in C57BL/6J mouse assessed as reduction of tumor weight at 5 mg/kg, ip dosed every 3 days for 17 days starting from 2 days after inoculation and co-treated with 5 mg/kg, ip EGFR inhibitor gefitinib relative to control	Mus musculus	1	ALA4610125	organism-based format	Scientific Literature
6.	ALA4613057	Toxicity	Toxicity in C57BL/6J mouse allografted with mouse LLC cells assessed as effect on body weight at 5 mg/kg, ip dosed every 3 days for 17 days starting from 2 days after inoculation	Mus musculus	1	ALA4610125	organism-based format	Scientific Literature
7.	ALA4613058	Toxicity	Toxicity in C57BL/6J mouse allografted with mouse LLC cells assessed as effect on body weight at 5 mg/kg, ip dosed every 3 days for 17 days starting from 2 days after inoculation and co-treated with 5 mg/kg, ip EGFR inhibitor gefitinib	Mus musculus	1	ALA4610125	organism-based format	Scientific Literature